Shaping a brighter future for brain cancer
Brain cancer is one of medicine’s toughest frontiers — but a new wave of innovation is shifting the landscape. Join us for an inspiring look at how scientists are re imagining the fight against brain tumours through cutting edge immunotherapy and precision medicine. In this talk, Professor Misty Jenkins will dive into how the immune system can be re engineered to detect and destroy tumour cells, and how the unique “fingerprint” of an individual cancer can guide truly personalised treatment strategies. Discover the latest breakthroughs, the promise of tailored therapies, and how these emerging approaches are bringing us closer to more effective — and more compassionate — care for people living with brain cancer.
Bio
Professor Misty Jenkins AO is an NHMRC Investigator Fellow and Laboratory Head in the Personalised Oncology Division at the Walter and Eliza Hall Institute of Medical Research (WEHI). She leads the Immunotherapy Program and is Co‑Director of Research Strategy at the Brain Cancer Centre. Her research focuses on identifying novel immunotherapy targets and developing CAR T cell therapies for adult and paediatric brain cancers, integrating high‑throughput screening, molecular engineering, advanced microscopy and mouse models. Professor Jenkins completed her PhD with Nobel Laureate Peter Doherty and postdoctoral training at Oxford, Cambridge and the Peter MacCallum Cancer Centre. She is an Officer of the Order of Australia and a Fellow of the Australian Academy of Technological Sciences and Engineering.
Event
Wednesday 13 May, 8:00 pm @La Di Da, 577 Little Bourke St, Melbourne VIC 3000
Also speaking at this location at 6:00 pm is Associate Professor Leo Chen
